Pharma Journalist 7879 posts 0 comments

National Resilience, Inc., a technology-focused biomanufacturing company dedicated to broadening access to complex medicines, proudly announces that its subsidiary, Resilience…
Read More...

Bristol Myers Squibb announced that the U.S. Food and Drug Administration (FDA) approved Opdivo  (nivolumab) for the treatment of adult patients with resectable (tumors ≥4 cm or node…
Read More...

Recordati announces an agreement with Sanofi to acquire the global rights to Enjaymo (sutimlimab), a biologic which is the only approved targeted product for the treatment of cold…
Read More...

Resolution Therapeutics Limited ("Resolution"), a clinical-stage biopharmaceutical company focused on unlocking the regenerative potential of macrophage therapy for the treatment of…
Read More...

Charles River Laboratories International, Inc. announced an agreement with H. Lundbeck A/S (Lundbeck) to utilize Logica to progress critical brain disease research. “We are excited…
Read More...

Arcus Biosciences, Inc. announced a clinical trial collaboration agreement with AstraZeneca to evaluate casdatifan (AB521), Arcus’s investigational HIF-2a inhibitor, in combination with…
Read More...

SK bioscience, a global innovative vaccine and biotech company committed to promoting human health from prevention to cure, announced the successful completion of its acquisition of a…
Read More...

ABL Bio (CEO Sang Hoon Lee), a company specializing in bispecific antibodies, announced that it has entered into a clinical trial collaboration and supply agreement with MSD (a…
Read More...

Gilead Sciences, Inc. announced that it has signed non-exclusive, royalty-free voluntary licensing agreements with six pharmaceutical manufacturers to make and sell generic lenacapavir,…
Read More...

ImmunoPrecise Antibodies Ltd., an AI-driven biotherapeutic research and technology company, and Biotheus Inc. (Biotheus), a clinical-stage biotech company dedicated to the discovery and…
Read More...